Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Nov;10(Suppl 33):S3875-S3877.
doi: 10.21037/jtd.2018.08.141.

A case for the smart use of smartwatch-based technologies

Affiliations
Editorial

A case for the smart use of smartwatch-based technologies

Tommaso Sanna. J Thorac Dis. 2018 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author is consultant to Medtronic and received speaker fees from Medtronic, Boehringer-Ingelheim, BMS-Pfeizer and Abiomed.

Figures

Figure 1
Figure 1
Atrial fibrillation (AF) pattern and AF detection by different electrocardiographic techniques. (A) Different patterns of AF are shown. Pattern a: long AF episode; Pattern b: short AF episode; Pattern c: multiple very short AF episodes. All patterns are detected by long-term continuous monitoring techniques; (B) AF detection with single standard electrocardiogram (EKG). Pattern a: detected; Pattern b: not detected; Pattern c: not detected; (C) AF detection with multiple regular smartwatch based technology (SBT) recordings: Pattern a: detected; Pattern b: detected; Pattern c: some episodes detected, some not.

Comment on

References

    1. Bumgarner JM, Lambert CT, Hussein AA, et al. Smartwatch Algorithm for Automated Detection of Atrial Fibrillation. J Am Coll Cardiol 2018;71:2381-8. 10.1016/j.jacc.2018.03.003 - DOI - PubMed
    1. Halcox JPJ, Wareham K, Cardew A, et al. Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study. Circulation 2017;136:1784-94. 10.1161/CIRCULATIONAHA.117.030583 - DOI - PubMed
    1. Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014;370:2478-86. 10.1056/NEJMoa1313600 - DOI - PubMed
    1. Lopes RD, Alings M, Connolly SJ, et al. Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial. Am Heart J 2017;189:137-45. 10.1016/j.ahj.2017.04.008 - DOI - PubMed
    1. Kirchhof P, Blank BF, Calvert M, et al. Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. Am Heart J 2017;190:12-8. 10.1016/j.ahj.2017.04.015 - DOI - PMC - PubMed